MEMS vs. ARKG ETF Comparison
Comparison of Matthews Emerging Markets Discovery Active ETF (MEMS) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
MEMS
Matthews Emerging Markets Discovery Active ETF
MEMS Description
MEMS aims to capitalize on growth opportunities within the emerging market space, including frontier markets. With a primary focus on small companies, the fund allocates at least 65% of its assets to the common and preferred stocks of these enterprises, with the remaining portion comprising mid-cap companies. The fund seeks sustainable growth based on fundamental characteristics such as balance sheet strength, employee count, cash flow stability, management quality, product lines, marketing strategies, corporate governance, and financial health. Additionally, exclusionary ESG screens may be employed to avoid controversial businesses, such as tobacco, weapons, and fossil fuels. The fund issuer may engage with its portfolio companies on sustainability and governance matters through active dialogue, exercising shareholder rights, and encouraging enhanced ESG disclosure and implementation. Up to 20% of the fund's assets may be invested in developed market companies, including ADRs and GDRs.
Grade (RS Rating)
Last Trade
$24.73
Average Daily Volume
7,598
3
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,215,896
34
Performance
| Period | MEMS | ARKG |
|---|---|---|
| 30 Days | -4.06% | -3.53% |
| 60 Days | -4.30% | -11.54% |
| 90 Days | -5.50% | -13.90% |
| 12 Months | -15.87% |
0 Overlapping Holdings
| Symbol | Grade | Weight in MEMS | Weight in ARKG | Overlap |
|---|
MEMS Underweight 34 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| TWST | F | -8.37% | |
| RXRX | F | -7.42% | |
| CRSP | D | -7.34% | |
| ADPT | C | -5.03% | |
| CDNA | D | -4.77% | |
| VCYT | B | -4.51% | |
| SDGR | C | -4.14% | |
| BEAM | D | -4.01% | |
| NTLA | F | -3.89% | |
| IONS | F | -3.85% | |
| NTRA | A | -3.82% | |
| NRIX | C | -3.78% | |
| TXG | F | -3.56% | |
| GH | B | -3.49% | |
| ARCT | F | -3.19% | |
| PSNL | D | -2.7% | |
| ABSI | F | -2.19% | |
| PACB | F | -2.16% | |
| BFLY | B | -1.71% | |
| VEEV | C | -1.7% | |
| AMGN | F | -1.68% | |
| ACCD | D | -1.47% | |
| VRTX | D | -1.29% | |
| ILMN | C | -1.25% | |
| CERS | D | -1.18% | |
| INCY | C | -1.11% | |
| REGN | F | -0.92% | |
| PRME | F | -0.9% | |
| CMPS | F | -0.75% | |
| MASS | F | -0.69% | |
| QSI | C | -0.68% | |
| EXAS | D | -0.65% | |
| RPTX | F | -0.64% | |
| MRNA | F | -0.01% |
MEMS: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords
Compare ETFs
